Human Neuronal Modeling of DLG4-Related Synaptopathy Reveals Network Dysfunction and Partial Rescue by Omega-3 Fatty Acid Docosahexaenoic Acid (DHA)
Cells · 17.09.2026 · 15 (18) · 1688
DOI: 10.3390/cells15181688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 17.09.2026. Verfasst von Gerardo Medina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Disks Large Homolog 4 Protein, Neurons, Synapses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DLG4 SHINE Foundation, CHEO RI, CHEO Foundation.
Abstract (Originalsprache)
DLG4-related synaptopathy (SHINE syndrome) is a rare neurodevelopmental disorder caused by pathogenic variants in DLG4, which encodes the postsynaptic scaffolding protein (PSD)-95, a central organizer of excitatory synapses. However, the cellular and network-level consequences of DLG4 haploinsufficiency in human neurons remain incompletely understood, and disease-targeted therapeutic strategies are lacking. Here, we used human induced neurons derived from an individual with SHINE syndrome to investigate the effects of PSD-95 deficiency on synaptic protein expression, neuronal morphology, and neuronal network activity. SHINE neurons exhibited reduced PSD-95 levels, impaired neurite morphology, reduced firing rate and burst frequency, prolonged burst duration, and reduced network synchrony. Treatment with the omega-3 (ω-3) polyunsaturated fatty acid docosahexaenoic acid (DHA) significantly increased PSD-95 protein levels and improved multiple parameters of neuronal network activity. DHA exposure was also associated with trends toward increased extracellular signal-regulated kinase and cAMP response element-binding protein phosphorylation. Together, these findings show that patient-derived SHINE neurons exhibit altered postsynaptic organization, neuronal morphology, and network function and provide evidence that DHA may partially restore synaptic and network function in this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.
- Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Eric Poulin Center for Neuromuscular Disease, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
ORCID-Profile: Gerardo Medina
Förderung
- DLG4 SHINE Foundation
- CHEO RI
- CHEO Foundation
Zitieren
APA
Medina, G., Rodriguez-Alcocer, L. A., Baird, S., & MacKenzie, A. E. (2026). Human Neuronal Modeling of DLG4-Related Synaptopathy Reveals Network Dysfunction and Partial Rescue by Omega-3 Fatty Acid Docosahexaenoic Acid (DHA). Cells, 15(18), 1688. https://doi.org/10.3390/cells15181688
Vancouver
Medina G, Rodriguez-Alcocer LA, Baird S, MacKenzie AE. Human Neuronal Modeling of DLG4-Related Synaptopathy Reveals Network Dysfunction and Partial Rescue by Omega-3 Fatty Acid Docosahexaenoic Acid (DHA). Cells. 2026;15(18):1688. doi:10.3390/cells15181688
BibTeX
@article{Medina2026,
author = {Medina, Gerardo and Rodriguez-Alcocer, Lilia A and Baird, Stephen and MacKenzie, Alex E},
title = {Human Neuronal Modeling of DLG4-Related Synaptopathy Reveals Network Dysfunction and Partial Rescue by Omega-3 Fatty Acid Docosahexaenoic Acid (DHA)},
journal = {Cells},
year = {2026},
volume = {15},
number = {18},
pages = {1688},
doi = {10.3390/cells15181688}
}
EUVIMED